Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Schizophrenia research and treatment, Treatment of Major Depression, Receptor Mechanisms and Signaling, and Neurotransmitter Receptor Influence on Behavior.
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials
Capturing changes in social functioning and positive affect using ecological momentary assessment during a 12-month trial of xanomeline and trospium chloride in schizophrenia
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia